ProfileGDS4718 / 206046_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 58% 64% 62% 61% 63% 59% 62% 60% 61% 64% 59% 67% 68% 59% 59% 58% 60% 61% 59% 60% 59% 61% 58% 58% 60% 60% 61% 59% 58% 62% 59% 58% 61% 60% 61% 59% 64% 63% 61% 62% 63% 64% 64% 58% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.9717158
GSM549102patient 115, normal, homogenized [OPG study]6.3767364
GSM549104patient 119, normal, homogenized [OPG study]6.2719962
GSM549108patient 138, normal, homogenized [OPG study]6.2367761
GSM549119patient 077, normal, homogenized [OPG study]6.3264863
GSM549133patient 032, cancer, homogenized [OPG study]6.059259
GSM549139patient 042, cancer, homogenized [OPG study]6.2799662
GSM549099patient 107, normal, homogenized [OPG study]6.1327360
GSM549109patient 139, normal, homogenized [OPG study]6.233561
GSM549110patient 046, normal, homogenized [OPG study]6.3876564
GSM549114patient 063, normal, homogenized [OPG study]6.0305359
GSM549122patient 082, normal, homogenized [OPG study]6.6353567
GSM549134patient 033, cancer, homogenized [OPG study]6.6721668
GSM549136patient 036, cancer, homogenized [OPG study]5.9928559
GSM549140patient 044, cancer, homogenized [OPG study]6.0300159
GSM549111patient 047, normal, homogenized [OPG study]6.0081658
GSM549113patient 057, normal, homogenized [OPG study]6.0838860
GSM549132patient 031, cancer, homogenized [OPG study]6.2008361
GSM549137patient 038, cancer, homogenized [OPG study]6.0863859
GSM549142patient 047, cancer, homogenized [OPG study]6.2133860
GSM549100patient 110, normal, homogenized [OPG study]6.0518459
GSM549107patient 135, normal, homogenized [OPG study]6.1768261
GSM549115patient 068, normal, homogenized [OPG study]5.978758
GSM549116patient 072, normal, homogenized [OPG study]5.9647558
GSM549120patient 078, normal, homogenized [OPG study]6.1589260
GSM549131patient 030, cancer, homogenized [OPG study]6.1051460
GSM549118patient 074, normal, homogenized [OPG study]6.2253461
GSM549129patient 027, cancer, homogenized [OPG study]6.0988459
GSM549123patient 088, normal, homogenized [OPG study]5.998758
GSM549124patient 006, cancer, homogenized [OPG study]6.2701862
GSM549126patient 015, cancer, homogenized [OPG study]6.0694159
GSM549128patient 025, cancer, homogenized [OPG study]6.002258
GSM549103patient 117, normal, homogenized [OPG study]6.1800261
GSM549117patient 073, normal, homogenized [OPG study]6.1018560
GSM549138patient 041, cancer, homogenized [OPG study]6.1967461
GSM549141patient 045, cancer, homogenized [OPG study]6.0814559
GSM549130patient 028, cancer, homogenized [OPG study]6.3958264
GSM549101patient 111, normal, homogenized [OPG study]6.3520163
GSM549105patient 128, normal, homogenized [OPG study]6.1904561
GSM549106patient 134, normal, homogenized [OPG study]6.2465862
GSM549112patient 048, normal, homogenized [OPG study]6.336763
GSM549125patient 011, cancer, homogenized [OPG study]6.3865564
GSM549127patient 024, cancer, homogenized [OPG study]6.4653864
GSM549135patient 035, cancer, homogenized [OPG study]5.9798958